selegiline has been researched along with 1-naphthylamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iacono, RP; Toyama, SC | 1 |
| Olanow, CW | 1 |
| Hayes, HD | 1 |
| Hauser, RA; Zesiewicz, TA | 1 |
1 trial(s) available for selegiline and 1-naphthylamine
| Article | Year |
|---|---|
Sertraline for the treatment of depression in Parkinson's disease.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Parkinson Disease; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
3 other study(ies) available for selegiline and 1-naphthylamine
| Article | Year |
|---|---|
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1994 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E | 1996 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antidepressive Agents; Antiparkinson Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1996 |